| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.005 | 1 |